{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:25:05Z","timestamp":1778768705944,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that is often aberrantly activated in cancer. However, mTORC1 inhibitors, such as rapamycin, have limited effectiveness as single agent cancer therapies, with feedback mechanisms inherent to the signaling network thought to diminish the anti-tumor effects of mTORC1 inhibition. Here, we identify the protein kinase and proto-oncogene PIM3 as being repressed downstream of mTORC1 signaling. PIM3 expression is suppressed in cells with loss of the tuberous sclerosis complex (TSC) tumor suppressors, which exhibit growth factor-independent activation of mTORC1, and in the mouse liver upon feeding-induced activation of mTORC1. Inhibition of mTORC1 with rapamycin induces PIM3 transcript and protein levels in a variety of settings. Suppression of PIM3 involves the sterol regulatory element-binding (SREBP) transcription factors SREBP1 and 2, whose activation and mRNA expression are stimulated by mTORC1 signaling. We find that PIM3 repression is mediated by miR-33, an intronic microRNA encoded within the SREBP loci, the expression of which is decreased with rapamycin. These results demonstrate that PIM3 is induced upon mTORC1 inhibition, with potential implications for the effects of mTORC1 inhibitors in TSC, cancers, and the many other disease settings influenced by aberrant mTORC1 signaling.<\/jats:p>","DOI":"10.1038\/s41598-017-16398-y","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T10:49:23Z","timestamp":1510915763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-6094","authenticated-orcid":false,"given":"Ilana","family":"Kelsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Byles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Torrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan D.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"issue":"Suppl 2","key":"16398_CR1","first-page":"51","volume":"27","author":"S Menon","year":"2008","unstructured":"Menon, S. & Manning, B. Common corruption of the mTOR signaling network in human tumors. Oncogene \n                           27(Suppl 2), 51 (2008).","journal-title":"Oncogene"},{"key":"16398_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","volume":"2","author":"E Ilagan","year":"2016","unstructured":"Ilagan, E. & Manning, B. D. Emerging role of mTOR in the response to cancer therapeutics. Trends in cancer \n                           2, 241\u2013251 (2016).","journal-title":"Trends in cancer"},{"key":"16398_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li, J., Kim, S. G. & Blenis, J. Rapamycin: one drug, many effects. Cell metabolism \n                           19, 373\u2013379 (2014).","journal-title":"Cell metabolism"},{"key":"16398_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR Signaling in Growth, Metabolism, and Disease. Cell \n                           169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"16398_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","volume":"45","author":"I Ben-Sahra","year":"2017","unstructured":"Ben-Sahra, I. & Manning, B. D. mTORC1 signaling and the metabolic control of cell growth. Current opinion in cell biology \n                           45, 72\u201382 (2017).","journal-title":"Current opinion in cell biology"},{"key":"16398_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang, J. & Manning, B. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. The Biochemical journal \n                           412, 179\u2013269 (2008).","journal-title":"The Biochemical journal"},{"key":"16398_CR7","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0503224102","volume":"102","author":"CM Johannessen","year":"2005","unstructured":"Johannessen, C. M. et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. PNAS \n                           102, 8573\u20138578 (2005).","journal-title":"PNAS"},{"key":"16398_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell \n                           121, 179\u2013193 (2005).","journal-title":"Cell"},{"key":"16398_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"B Manning","year":"2002","unstructured":"Manning, B., Tee, A., Logsdon, M., Blenis, J. & Cantley, L. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Molecular cell \n                           10, 151\u2013162 (2002).","journal-title":"Molecular cell"},{"key":"16398_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature cell biology \n                           4, 648\u2013657 (2002).","journal-title":"Nature cell biology"},{"key":"16398_CR11","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"P Roux","year":"2004","unstructured":"Roux, P., Ballif, B., Anjum, R., Gygi, S. & Blenis, J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. PNAS \n                           101, 13489\u201313494 (2004).","journal-title":"PNAS"},{"key":"16398_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/onc.2015.179","volume":"35","author":"SJH Ricoult","year":"2016","unstructured":"Ricoult, S. J. H., Yecies, J. L., Ben-Sahra, I. & Manning, B. D. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene \n                           35, 1250\u20131260 (2016).","journal-title":"Oncogene"},{"key":"16398_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1228792","volume":"339","author":"I Ben-Sahra","year":"2013","unstructured":"Ben-Sahra, I., Howell, J. J., Asara, J. M. & Manning, B. D. Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1. Science \n                           339, 1323\u20131328 (2013).","journal-title":"Science"},{"key":"16398_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.aad0489","volume":"351","author":"I Ben-Sahra","year":"2016","unstructured":"Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. J., Asara, J. M. & Manning, B. D. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science \n                           351, 728\u2013733 (2016).","journal-title":"Science"},{"key":"16398_CR15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.1228771","volume":"339","author":"AM Robitaille","year":"2013","unstructured":"Robitaille, A. M. et al. Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis. Science \n                           339, 1320\u20131323 (2013).","journal-title":"Science"},{"key":"16398_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature \n                           485, 55\u201361 (2012).","journal-title":"Nature"},{"key":"16398_CR17","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"C Thoreen","year":"2009","unstructured":"Thoreen, C. et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. The Journal of biological chemistry \n                           284, 8023\u20138055 (2009).","journal-title":"The Journal of biological chemistry"},{"key":"16398_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K D\u00fcvel","year":"2010","unstructured":"D\u00fcvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular cell \n                           39, 171\u2013254 (2010).","journal-title":"Molecular cell"},{"key":"16398_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ncb2763","volume":"15","author":"CC Dibble","year":"2013","unstructured":"Dibble, C. C. & Manning, B. D. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nature cell biology \n                           15, 555\u2013564 (2013).","journal-title":"Nature cell biology"},{"key":"16398_CR20","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1128\/MCB.22.15.5575-5584.2002","volume":"22","author":"T Peng","year":"2002","unstructured":"Peng, T., Golub, T. R. & Sabatini, D. M. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Molecular and cellular biology \n                           22, 5575\u20135584 (2002).","journal-title":"Molecular and cellular biology"},{"key":"16398_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu, P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science \n                           332, 1317\u20131322 (2011).","journal-title":"Science"},{"key":"16398_CR22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science \n                           332, 1322\u20131326 (2011).","journal-title":"Science"},{"key":"16398_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/embor.2013.5","volume":"14","author":"SJH Ricoult","year":"2013","unstructured":"Ricoult, S. J. H. & Manning, B. D. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO reports \n                           14, 242\u2013251 (2013).","journal-title":"EMBO reports"},{"key":"16398_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"J Yecies","year":"2011","unstructured":"Yecies, J. et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell metabolism \n                           14, 21\u201353 (2011).","journal-title":"Cell metabolism"},{"key":"16398_CR25","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1073\/pnas.0914798107","volume":"107","author":"S Li","year":"2010","unstructured":"Li, S., Brown, M. S. & Goldstein, J. L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. PNAS \n                           107, 3441\u20133446 (2010).","journal-title":"PNAS"},{"key":"16398_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab \n                           8, 224\u2013236 (2008).","journal-title":"Cell Metab"},{"key":"16398_CR27","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science \n                           328, 1566\u20131569 (2010).","journal-title":"Science"},{"key":"16398_CR28","first-page":"1568","volume":"146","author":"SR Howe","year":"1995","unstructured":"Howe, S. R. et al. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. The American journal of pathology \n                           146, 1568\u20131579 (1995).","journal-title":"The American journal of pathology"},{"key":"16398_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"T-I Jeon","year":"2012","unstructured":"Jeon, T.-I. & Osborne, T. F. SREBPs: metabolic integrators in physiology and metabolism. Trends in Endocrinology & Metabolism \n                           23, 65\u201372 (2012).","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"16398_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00125-013-3136-1","volume":"57","author":"Y Bi","year":"2014","unstructured":"Bi, Y. et al. Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription. Diabetologia \n                           57, 592\u2013602 (2014).","journal-title":"Diabetologia"},{"key":"16398_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1158\/1541-7786.MCR-07-0354","volume":"6","author":"JH Suh","year":"2008","unstructured":"Suh, J. H. et al. Sterol Regulatory Element\u2013Binding Protein-1c Represses the Transactivation of Androgen Receptor and Androgen-Dependent Growth of Prostatic Cells. Molecular Cancer Research \n                           6, 314\u2013324 (2008).","journal-title":"Molecular Cancer Research"},{"key":"16398_CR32","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1073\/pnas.1102281108","volume":"108","author":"A D\u00e1valos","year":"2011","unstructured":"D\u00e1valos, A. et al. miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. PNAS \n                           108, 9232\u20139237 (2011).","journal-title":"PNAS"},{"key":"16398_CR33","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife \n                           4 (2015).","DOI":"10.7554\/eLife.05005"},{"key":"16398_CR34","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.18632\/oncotarget.3885","volume":"6","author":"C Liang","year":"2015","unstructured":"Liang, C. et al. MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine. Oncotarget \n                           6, 14440\u201314455 (2015).","journal-title":"Oncotarget"},{"key":"16398_CR35","doi-asserted-by":"publisher","first-page":"26461","DOI":"10.1074\/jbc.271.43.26461","volume":"271","author":"R Sato","year":"1996","unstructured":"Sato, R. et al. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. The Journal of biological chemistry \n                           271, 26461\u201326464 (1996).","journal-title":"The Journal of biological chemistry"},{"key":"16398_CR36","doi-asserted-by":"publisher","first-page":"31078","DOI":"10.1074\/jbc.M005353200","volume":"275","author":"M Amemiya-Kudo","year":"2000","unstructured":"Amemiya-Kudo, M. et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. The Journal of biological chemistry \n                           275, 31078\u201331085 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"16398_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc2986","volume":"11","author":"MC Nawijn","year":"2011","unstructured":"Nawijn, M. C., Alendar, A. & Berns, A. For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer \n                           11, 23\u201334 (2011).","journal-title":"Nat Rev Cancer"},{"key":"16398_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/onc.2011.278","volume":"31","author":"M Thomas","year":"2012","unstructured":"Thomas, M. et al. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene \n                           31, 918\u2013928 (2012).","journal-title":"Oncogene"},{"key":"16398_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nature reviews. Genetics \n                           16, 421\u2013433 (2015).","journal-title":"Nature reviews. Genetics"},{"key":"16398_CR40","unstructured":"Elkabets, M. et al. mTORC1 Inhibition Is Required for Sensitivity to PI3Kp110\u03b1 Inhibitors in PIK3CA-Mutant Breast Cancer. Science translational medicine \n                           5 (2013)."},{"key":"16398_CR41","doi-asserted-by":"crossref","unstructured":"Corcoran, R. et al. TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma. Science translational medicine \n                           5 (2013).","DOI":"10.1126\/scitranslmed.3005753"},{"key":"16398_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cmet.2017.04.004","volume":"25","author":"AC Kimmelman","year":"2017","unstructured":"Kimmelman, A. C. & White, E. Autophagy and Tumor Metabolism. Cell metabolism \n                           25, 1037\u20131043 (2017).","journal-title":"Cell metabolism"},{"key":"16398_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB Signaling: Navigating the Network. Cell \n                           169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"16398_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tibs.2014.08.010","volume":"39","author":"C Sun","year":"2014","unstructured":"Sun, C. & Bernards, R. Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies. Trends in biochemical sciences \n                           39, 465\u2013474 (2014).","journal-title":"Trends in biochemical sciences"},{"key":"16398_CR45","doi-asserted-by":"publisher","first-page":"41675","DOI":"10.1074\/jbc.M510711200","volume":"280","author":"AN Bullock","year":"2005","unstructured":"Bullock, A. N., Debreczeni, J., Amos, A. L., Knapp, S. & Turk, B. E. Structure and Substrate Specificity of the Pim-1 Kinase. Journal of Biological Chemistry \n                           280, 41675\u201341682 (2005).","journal-title":"Journal of Biological Chemistry"},{"key":"16398_CR46","doi-asserted-by":"publisher","first-page":"36108","DOI":"10.1074\/jbc.M005497200","volume":"275","author":"T Obata","year":"2000","unstructured":"Obata, T. et al. Peptide and protein library screening defines optimal substrate motifs for AKT\/PKB. The Journal of biological chemistry \n                           275, 36108\u201336115 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"16398_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pharmthera.2015.03.001","volume":"151","author":"NA Warfel","year":"2015","unstructured":"Warfel, N. A. & Kraft, A. S. PIM kinase (and Akt) biology and signaling in tumors. Pharmacology & Therapeutics \n                           151, 41\u201349 (2015).","journal-title":"Pharmacology & Therapeutics"},{"key":"16398_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1349-7006.2008.01059.x","volume":"100","author":"Y-Y Li","year":"2009","unstructured":"Li, Y.-Y., Wu, Y., Tsuneyama, K., Baba, T. & Mukaida, N. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells. Cancer science \n                           100, 396\u2013800 (2009).","journal-title":"Cancer science"},{"key":"16398_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/1541-7786.MCR-04-0192","volume":"3","author":"KP Shay","year":"2005","unstructured":"Shay, K. P., Wang, Z., Xing, P. X., McKenzie, I. F. & Magnuson, N. S. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Molecular cancer research: MCR \n                           3, 170\u2013181 (2005).","journal-title":"Molecular cancer research: MCR"},{"key":"16398_CR50","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood.V93.6.1980.406k20_1980_1991","volume":"93","author":"S Matikainen","year":"1999","unstructured":"Matikainen, S. et al. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood \n                           93, 1980\u20131991 (1999).","journal-title":"Blood"},{"key":"16398_CR51","doi-asserted-by":"publisher","first-page":"e88301","DOI":"10.1371\/journal.pone.0088301","volume":"9","author":"Z Yu","year":"2014","unstructured":"Yu, Z. et al. A regulatory feedback loop between HIF-1alpha and PIM2 in HepG2 cells. PLoS One \n                           9, e88301 (2014).","journal-title":"PLoS One"},{"key":"16398_CR52","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1007\/s13277-016-5295-4","volume":"37","author":"W Chang","year":"2016","unstructured":"Chang, W. et al. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Tumor Biology \n                           37, 14813\u201314824 (2016).","journal-title":"Tumor Biology"},{"key":"16398_CR53","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4161\/cbt.8.9.8210","volume":"8","author":"F Zhang","year":"2009","unstructured":"Zhang, F. et al. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer biology & therapy \n                           8, 846\u2013853 (2009).","journal-title":"Cancer biology & therapy"},{"key":"16398_CR54","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1182\/blood-2013-01-481457","volume":"122","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation. Blood \n                           122, 1610\u20131620 (2013).","journal-title":"Blood"},{"key":"16398_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1158\/2159-8290.CD-16-0305","volume":"6","author":"X Le","year":"2016","unstructured":"Le, X. et al. Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer. Cancer discovery \n                           6, 1134\u20131147 (2016).","journal-title":"Cancer discovery"},{"key":"16398_CR56","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1074\/jbc.M112.416446","volume":"288","author":"H Totary-Jain","year":"2013","unstructured":"Totary-Jain, H. et al. Reprogramming of the microRNA transcriptome mediates resistance to rapamycin. The Journal of biological chemistry \n                           288, 6034\u20136044 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"16398_CR57","doi-asserted-by":"publisher","first-page":"e60014","DOI":"10.1371\/journal.pone.0060014","volume":"8","author":"AJ Trindade","year":"2013","unstructured":"Trindade, A. J. et al. MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM). PloS one \n                           8, e60014 (2013).","journal-title":"PloS one"},{"key":"16398_CR58","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.molcel.2014.12.034","volume":"57","author":"P Ye","year":"2015","unstructured":"Ye, P. et al. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular cell \n                           57, 708\u2013720 (2015).","journal-title":"Molecular cell"},{"key":"16398_CR59","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.12659\/MSM.902692","volume":"23","author":"W Meng","year":"2017","unstructured":"Meng, W. et al. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance. Medical science monitor \n                           23, 1295\u20131304 (2017).","journal-title":"Medical science monitor"},{"key":"16398_CR60","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ijrobp.2016.01.025","volume":"95","author":"AR Wolfe","year":"2016","unstructured":"Wolfe, A. R. et al. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. International Journal of Radiation Oncology*Biology*Physics \n                           95, 791\u2013799 (2016).","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"16398_CR61","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/15384047.2015.1030545","volume":"16","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1\u03b1. Cancer Biology & Therapy \n                           16, 846\u2013855 (2015).","journal-title":"Cancer Biology & Therapy"},{"key":"16398_CR62","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science (New York, N.Y.) \n                           328, 1570\u20131573 (2010).","journal-title":"Science (New York, N.Y.)"},{"key":"16398_CR63","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1161\/ATVBAHA.116.308472","volume":"36","author":"A Katsube","year":"2016","unstructured":"Katsube, A., Hayashi, H. & Kusuhara, H. Pim-1L Protects Cell Surface-Resident ABCA1 From Lysosomal Degradation in Hepatocytes and Thereby Regulates Plasma High-Density Lipoprotein Level. Arteriosclerosis, thrombosis, and vascular biology \n                           36, 2304\u20132314 (2016).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"16398_CR64","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.18632\/oncotarget.3534","volume":"6","author":"C Leung","year":"2015","unstructured":"Leung, C. et al. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget \n                           6, 10880\u201310892 (2015).","journal-title":"Oncotarget"},{"key":"16398_CR65","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1073\/pnas.1013214108","volume":"108","author":"Z Beharry","year":"2011","unstructured":"Beharry, Z. et al. The Pim protein kinases regulate energy metabolism and cell growth. PNAS \n                           108, 528\u2013533 (2011).","journal-title":"PNAS"},{"key":"16398_CR66","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/CIRCRESAHA.109.212035","volume":"106","author":"GA Borillo","year":"2010","unstructured":"Borillo, G. A. et al. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circulation research \n                           106, 1265\u20131274 (2010).","journal-title":"Circulation research"},{"key":"16398_CR67","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/CIRCRESAHA.115.304441","volume":"115","author":"S Din","year":"2014","unstructured":"Din, S. et al. Metabolic Dysfunction Consistent With Premature Aging Results From Deletion of Pim Kinases. Circulation Research \n                           115, 376\u2013387 (2014).","journal-title":"Circulation Research"},{"key":"16398_CR68","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/onc.2009.504","volume":"29","author":"Y Wu","year":"2010","unstructured":"Wu, Y. et al. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene \n                           29, 2228\u20132237 (2010).","journal-title":"Oncogene"},{"key":"16398_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura, A. et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell metabolism \n                           20, 133\u2013144 (2014).","journal-title":"Cell metabolism"},{"key":"16398_CR70","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski, D. J. et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet \n                           11, 525\u2013534 (2002).","journal-title":"Hum Mol Genet"},{"key":"16398_CR71","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI200317222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang, H. et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest \n                           112, 1223\u20131233 (2003).","journal-title":"J Clin Invest"},{"key":"16398_CR72","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.1038\/sj.onc.1205962","volume":"21","author":"A Astrinidis","year":"2002","unstructured":"Astrinidis, A. et al. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene \n                           21, 8470\u20138476 (2002).","journal-title":"Oncogene"},{"key":"16398_CR73","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1128\/MCB.23.17.6139-6149.2003","volume":"23","author":"A Radu","year":"2003","unstructured":"Radu, A., Neubauer, V., Akagi, T., Hanafusa, H. & Georgescu, M. M. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Molecular and cellular biology \n                           23, 6139\u20136149 (2003).","journal-title":"Molecular and cellular biology"},{"key":"16398_CR74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","volume":"13","author":"V Rottiers","year":"2012","unstructured":"Rottiers, V. & Naar, A. M. MicroRNAs in metabolism and metabolic disorders. Nature reviews. Molecular cell biology \n                           13, 239\u2013250 (2012).","journal-title":"Nature reviews. Molecular cell biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16398-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:02:26Z","timestamp":1671804146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16398-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["16398"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-16398-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.K., M.Z., V.B., and M.T. declare no potential conflict of interest. B.D.M. is a member of the scientific advisory boards and a shareholder for Navitor Pharmaceuticals and LAM Therapeutics and has received compensation for these roles.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16112"}}